Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 7.50 ($0.09) and last traded at GBX 7.20 ($0.09), with a volume of 2510080 shares traded. The stock had previously closed at GBX 7 ($0.09).
Allergy Therapeutics Trading Up 2.9 %
The firm has a market cap of £343.44 million, a PE ratio of -120.00, a PEG ratio of -30.70 and a beta of 1.40. The firm has a fifty day simple moving average of GBX 5.75 and a two-hundred day simple moving average of GBX 5.12. The company has a current ratio of 1.40, a quick ratio of 1.48 and a debt-to-equity ratio of 37.22.
Allergy Therapeutics Company Profile
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Read More
- Five stocks we like better than Allergy Therapeutics
- When to Sell a Stock for Profit or Loss
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How Can Investors Benefit From After-Hours Trading
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Earnings Per Share Calculator: How to Calculate EPS
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
